HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T-5224, a selective inhibitor of c-Fos/activator protein-1, attenuates lipopolysaccharide-induced liver injury in mice.

Abstract
The effect of T-5224, a selective inhibitor of c-Fos/activator protein (AP)-1, on lipopolysaccharide (LPS) induced liver injury was examined in mice. Administration of LPS (10 mg kg(-1), i.p.) markedly increased serum levels of tumor necrosis factor-alpha (TNFα), high mobility group box 1 (HMGB1), alanine aminotransferase/aspartate aminotransferase (ALT/AST), liver tissue levels of macrophage-inflammatory protein-1 alpha (MIP-1α) and monocyte chemoattractant protein-1 (MCP-1), as well as hepatic necrosis and inflammation, leading to 67 % lethality. Administration of T-5224 (300 mg kg(-1), p.o.) after intraperitoneal injection of LPS imparted appreciable protection against acute elevations in serum levels of TNFα, HMGB1, ALT/AST as well as in liver tissue levels of MIP-1α and MCP-1, and reduced the lethality (27 %). These data indicate that T-5224 ameliorates liver injury and improves survival through decreasing production of proinflammatory cytokines and chemokines in endotoxemic mice.
AuthorsShinichiro Izuta, Masaaki Ueki, Masaki Ueno, Kahoru Nishina, Shunichi Shiozawa, Nobuhiro Maekawa
JournalBiotechnology letters (Biotechnol Lett) Vol. 34 Issue 12 Pg. 2175-82 (Dec 2012) ISSN: 1573-6776 [Electronic] Netherlands
PMID22927112 (Publication Type: Journal Article)
Chemical References
  • 3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid
  • Benzophenones
  • Cytokines
  • Enzymes
  • Gastrointestinal Agents
  • Isoxazoles
  • Lipopolysaccharides
Topics
  • Animals
  • Benzophenones (administration & dosage, pharmacology)
  • Chemical and Drug Induced Liver Injury (prevention & control)
  • Cytokines (blood)
  • Disease Models, Animal
  • Enzymes (blood)
  • Gastrointestinal Agents (administration & dosage, pharmacology)
  • Hepatitis, Animal (chemically induced, prevention & control)
  • Isoxazoles (administration & dosage, pharmacology)
  • Lipopolysaccharides (toxicity)
  • Liver (drug effects, pathology)
  • Mice
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: